Gland Pharma Limited (NSE:GLAND)
1,976.50
+47.60 (2.47%)
Nov 3, 2025, 2:30 PM IST
Revenue by Product
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Revenue by Geography
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.